Striatal dopamine D2 receptors in tardive dyskinesia: PET study
- PMID: 2574230
- PMCID: PMC1031632
- DOI: 10.1136/jnnp.52.11.1248
Striatal dopamine D2 receptors in tardive dyskinesia: PET study
Abstract
The dopamine D2 receptors were investigated in vivo in eight neuroleptic-free patients with persistent tardive dyskinesia using positron emission tomography and 76Br-bromospiperone. The striatal receptor density, estimated by the striatum/cerebellum radioligand concentration ratio, was not elevated in patients as compared with age-matched controls but was positively correlated with the severity of orofacial dyskinesia assessed with the Abnormal Involuntary Movement Rating Scale. These results indicate that tardive dyskinesia is associated with normal levels of striatal D2 receptors but the severity of orofacial movements may depend on the relative density of striatal D2 receptors.
Similar articles
-
High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.Biol Psychiatry. 1991 Apr 1;29(7):629-34. doi: 10.1016/0006-3223(91)90132-6. Biol Psychiatry. 1991. PMID: 1675892
-
Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding.J Neural Transm Gen Sect. 1990;79(3):215-26. doi: 10.1007/BF01245132. J Neural Transm Gen Sect. 1990. PMID: 2137000
-
Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics.Psychiatry Res. 1989 Sep;29(3):357-8. doi: 10.1016/0165-1781(89)90088-7. Psychiatry Res. 1989. PMID: 2575262 No abstract available.
-
Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.Biol Psychiatry. 1993 Nov 15;34(10):713-38. doi: 10.1016/0006-3223(93)90044-e. Biol Psychiatry. 1993. PMID: 7904833 Review.
-
Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes.J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):3S-9S. doi: 10.1097/00004714-198808001-00002. J Clin Psychopharmacol. 1988. PMID: 2906067 Review.
Cited by
-
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.Psychopharmacology (Berl). 1989;99(4):463-72. doi: 10.1007/BF00589893. Psychopharmacology (Berl). 1989. PMID: 2574481
-
Structural and functional brain imaging in schizophrenia.J Psychiatry Neurosci. 1991 Jul;16(2):53-74. J Psychiatry Neurosci. 1991. PMID: 1911736 Free PMC article. Review.
-
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.Psychopharmacology (Berl). 1993;112(2-3):389-97. doi: 10.1007/BF02244938. Psychopharmacology (Berl). 1993. PMID: 7871047
-
Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study.J Neural Transm Gen Sect. 1992;87(3):225-30. doi: 10.1007/BF01245368. J Neural Transm Gen Sect. 1992. PMID: 1533773
-
Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders.Pharmgenomics Pers Med. 2014 Oct 13;7:317-28. doi: 10.2147/PGPM.S52806. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25378945 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical